Biotech firm touts new AI lung disease drug discovery amid third Hong Kong IPO attempt
Biotechnology firm Insilico Medicine said its new drug for lung disease, designed with the help of
artificial intelligence (AI) , showed positive results in the latest clinical trials, as the company pushes for a public listing in Hong Kong.
Advertisement
Insilico found that its new small-molecule drug candidate, rentosertib, designed with its AI platform Chemistry42, was 'generally safe and potentially effective' for treating idiopathic pulmonary fibrosis (IPF), according to its phase 2A clinical trial results published in the journal Nature Medicine on Tuesday.
IPF is a chronic disease that causes lung tissue to thicken and stiffen, leading to breathing difficulties. During a 12-week study of rentosertib, which enrolled 71 patients in China, Insilico observed an improvement in lung function for those who received a higher dose, according to the paper.
While adverse reactions related to liver toxicity occurred in some patients who were also taking another IPF drug, rentosertib met its safety objectives for the trial, Insilico said.
The study showed the 'transformative potential of AI in drug discovery and development', paving the way for faster and more innovative therapeutic advancements, Insilico founder and CEO Alex Zhavoronkov said in a statement.
Insilico Medicine founder and CEO Alex Zhavoronkov believes AI makes it easier for emerging countries to take part in drug discovery. Photo: Handout
Insilico was founded in 2014 in Baltimore, Maryland, as part of the Emerging Technology Centre at Johns Hopkins University. The company announced last year that it had moved its global headquarters to Boston. It has a significant presence in mainland China, with a lab in Suzhou, and Hong Kong, where it has an office at Science Park.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South China Morning Post
an hour ago
- South China Morning Post
Central Asia friendship pact bolsters stability
Amid wars in the Middle East and Eastern Europe and geopolitical tensions, Central Asia is a comparative oasis of peace, stability and cooperation. This was reflected this week in the second China-Central Asia Summit. Advertisement The six countries signed a landmark permanent friendship pact, and President Xi Jinping pledged 1.5 billion yuan (HK$1.6 billion) in livelihood and development assistance to China's five partners – Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan and Uzbekistan. China shares land borders with 14 neighbouring countries, and Central Asia is one of the least troublesome regions. In his keynote summit address, Xi stressed the need for cooperation amid global upheaval and transformation. Reiterating that there would be no winners in the tariff and trade war, he said: 'Supporters of protectionism and hegemonism will harm others and themselves.' The region, where Russia is historically dominant, is integral to Beijing's Belt and Road Initiative global development strategy, evidenced by heavy investment in energy pipelines, infrastructure and mining projects. Expansion plans include renewable energy and sustainable development – a focus of Xi's talks with the leaders of the five states. He also defended multilateralism and the global trade order at meetings, reflecting China's efforts to position itself as a reliable trade partner. Advertisement Beijing sees terrorism, separatism and extremism as threats to national and regional security, and Xi returned to this theme repeatedly in meetings with leaders. Notwithstanding the historical emphasis on economic development in the region, China has expanded its security presence through joint counterterrorism exercises, training programmes and aid.
South China Morning Post
an hour ago
- South China Morning Post
Why has China set up a new Hong Kong-based international mediation body?
China is seeking to become the chief architect of new models of global governance in the wake of the rapid retreat of the US from the international stage under Donald Trump, with Beijing saying the existing mechanisms do not properly represent the interests of developing nations. One striking example came last month when Beijing launched the International Organisation for Mediation (IOMed) , which it described as the world's first intergovernmental legal body dedicated to mediation that would help 'fill an institutional gap'. Placing the organisation in Hong Kong also sent a message to the world that the city is moving beyond its traditional image as a gateway to the mainland's economy and can play an increasingly political role as China's bridge to the Global South. A rare trip by Chinese Foreign Minister Wang Yi to Hong Kong at the end of May for IOMed's convention signing ceremony also highlighted Beijing's ambition to reach out to developing countries as a way of enhancing its global prominence. 'Let's improve the participation of developing countries … and strengthen the representation and voice of the Global South in international governance,' Wang said during his speech at the signing ceremony. He added that the body was 'intended to fill a gap in the existing international mediation mechanisms and serve as an important rule-of-law public good for improving global governance'. 'Building IOMed is an important effort by China to participate in global governance and to expand multilateral mechanisms in action,' said Zhu Feng, the executive dean of Nanjing University's school of international studies.
South China Morning Post
2 hours ago
- South China Morning Post
Hong Kong's research strength is vital to China's third wave of reform
As Shenzhen approaches 45 years as a special economic zone (SEZ), the importance of opening up in driving China's progress was stressed by none other than Huawei Technologies founder Ren Zhengfei. 'The more open the country becomes, the more it will drive our progress,' he told People's Daily in a recent interview, speaking also of the importance of basic research, education and talent development. Soon after, the government outlined reforms to accelerate the development of hi-tech emerging industries in Shenzhen, highlighting the pioneering and demonstrative role of the reforms to push innovation and opening-up. Shenzhen has long been the vanguard of China's reform and opening-up. The decision to create the Shenzhen SEZ in the first wave of reform was groundbreaking and marked China's entry into global markets. The second wave of opening up kicked off with Deng Xiaoping's 1992 'southern tour' . China seized the opportunities presented by the post-Cold War wave of globalisation, breaking free of sanctions and restrictions. In 2001, China's accession to the World Trade Organization furthered its integration into the global economy, solidifying its position as a key player and laying the foundation for its rise as a major power. Today, however, China needs to enter a new phase of opening up – a third wave – and Shenzhen's latest reform agenda is viewed as a key precursor to this shift. China is facing a more complex and uncertain global environment, characterised by escalating geopolitical tensions, economic decoupling and a fierce technological cold war with the United States. Unlike previously, this new phase will require a strategic recalibration – focusing on technological innovation and talent cultivation.
